Tivicay Pd Tablet, For Suspension
Product Images NDC 49702-255

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tivicay Pd (NDC 49702-255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dolutegravir Chemical Structure (Tivicay Spl Graphic 01)

FDA Label Image

Tivicay 10 mg 30 Count Label (Tivicay Spl Graphic 02)

FDA Label Image

Tivicay 25 mg Count Label (Tivicay Spl Graphic 03)

FDA Label Image

Tivicay 50 mg 30 Count Label (Tivicay Spl Graphic 04)

FDA Label Image

Tivicay Spl Graphic 05

Tivicay Spl Graphic 05
This is a very brief and simple instruction telling someone to administer medicine to a child.*
FDA Label Image

Tivicay Spl Graphic 06

Tivicay Spl Graphic 06
This text is a simple instruction stating to administer medicine to an infant.*
FDA Label Image

Tivicay Spl Graphic 07

FDA Label Image

Tivicay Spl Graphic 08

Tivicay Spl Graphic 08
This is a prescription medication called TivicayPD with the active ingredient dolutegravir. It is available in tablet form and is not interchangeable with other medications. Each tablet contains 5mg of dolutegravir, and the bottle comes with 60 tablets and a dosing syringe and cup. The medication should not be chewed, cut, or crushed, and should not be used if the membrane seal under the cap is missing or broken. The prescribing information should be consulted for dosing instructions.*
FDA Label Image

Tivicay Spl Graphic 09

Tivicay Spl Graphic 09
This is a prescription drug with the name Tivicay, whose active ingredient is dolutegravir. It comes in a film-coated tablet formulation with each tablet containing 10 mg of dolutegravir in the form of dolutegravir sodium. It is packed in a bottle containing 30 tablets and should be stored at controlled room temperature. The prescribing information should be consulted for dosage recommendations. The drug is marketed by ViiV Healthcare.*
FDA Label Image

Tivicay Spl Graphic 10

Tivicay Spl Graphic 10
This is a medication with the name "Ivica" (dolutegravir) which comes in film-coated tablet form with each tablet containing 25mg of dolutegravir sodium. It is a prescription medication with dosage information on the prescribing information. It should be stored at a controlled room temperature of 25°C, with excursions permitted at 10-30°C (59° to 86°F). The manufacturer is located in Research Triangle Park, NC 27709, and it is made in Japan.*
FDA Label Image

Tivicay Spl Graphic 11

Tivicay Spl Graphic 11
This is a prescription drug called Tivicay (dolutegravir) used for treating HIV. Each film-coated tablet contains dolutegravir sodium equivalent to 50 mg of dolutegravir. It comes in a bottle of 30 tablets and should be stored at a controlled room temperature of 25°C (77°F), with excursions permitted to 15°t0 30°C (59° to 86°F). The manufacturer is ViiV Healthcare based in Research Triangle Park, NC, and the medication is made in Japan. For dosage information, please refer to the prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.